ASX Share rice
Fri 14 Aug 2020 - 09:50:pm (Sydney)

OBJ Share Price

OBJ LIMITEDOBJPharmaceuticals, Biotechnology & Life Sciences

OBJ Company Information


OBJ Limited




Diagnostics & Research

GIC Industry:


GIC Sub Industry:



284 Oxford Street Leederville WA Australia 6007


61 8 9443 3011

Founder, MD, Technical Director & Exec. Director:

Mr. Jeffrey David Edwards

Chief Exec. Officer:

Mr. Paul Peros

Chief Scientific Officer:

Dr. Matthew McIldowie

Company Sec.:

Mr. John Joseph Palermo B.Bus, CA, FCA, ASCA, J.P., ACIS, AGIA, Snr

Scientific Adviser:

Dr. Michael Roberts

Company Overview:

OBJ Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. OBJ Limited was founded in 2004 and is based in Leederville, Australia.

OBJ Share Price Information

Shares Issued:


Dividend Yield:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


OBJ CashFlow Statement

CashFlow Date:


Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Capital Expenditures:


OBJ Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


OBJ Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Accounts Payable:


OBJ Share Price History

OBJ News

13 Jan, 2020
Little Green Pharma Ltd (“LGP”) has applied to list on the ASX, with a target listing date of February 7th, 2020 under the symbol ‘LGP’. Elixxer is currently the largest shareholder and supports LGP’s expansion plan throughout Australia and international markets into Europe. LGP is currently expanding operations in Australia to increase their current production from 15,000 bottles of medical cannabis oil per year to over 110,000 bottles.
03 Oct, 2019
The CEO of OBJ Limited (ASX:OBJ) is Jeff Edwards. First, this article will compare CEO compensation with compensation...